# Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study (CASES-PMS)

> **NCT00231231** · PHASE3 · COMPLETED · sponsor: **Cordis US Corp.** · enrollment: 1500 (—)

## Conditions studied

- Carotid Artery Disease

## Interventions

- **DEVICE:** -PRECISE Nitinol Stent System (5F, 5.5F and 6F)
- **DEVICE:** ANGIOGUARD™ XP Emboli Capture Guidewire (ECGW)

## Key facts

- **NCT ID:** NCT00231231
- **Lead sponsor:** Cordis US Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** 2006-11
- **Target enrollment:** 1500 (—)
- **Last updated:** 2007-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00231231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00231231, "Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study (CASES-PMS)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00231231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*